These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 4080094)
41. The impaired expression of glycine decarboxylase in patients with hyperglycinemias. Kume A; Kure S; Tada K; Hiraga K Biochem Biophys Res Commun; 1988 Jul; 154(1):292-7. PubMed ID: 3395333 [TBL] [Abstract][Full Text] [Related]
42. [Hereditary hyperglycinemia. Clinical picture and determination of glycoxylic and oxalic acids in the urines of one patient each with acidotic and nonacidotic form]. Rampini S; Vischer D; Curtius HC; Anders PW; Tancredi F; Frischknecht W; Prader A Helv Paediatr Acta; 1967 May; 22(2):135-59. PubMed ID: 5584591 [No Abstract] [Full Text] [Related]
43. Nonketotic hyperglycinemia in a newborn infant. Tekinalp G; Coşkun T; Oran O; Ozalp I; Figen G; Ergin H Turk J Pediatr; 1995; 37(1):57-60. PubMed ID: 7732609 [TBL] [Abstract][Full Text] [Related]
44. Early treatment of severe infantile glycine encephalopathy (nonketotic hyperglycinemia) with strychnine and sodium benzoate. Melançon SB; Dallaire L; Vincelette P; Potier M; Geoffroy G Prog Clin Biol Res; 1979; 34():217-29. PubMed ID: 531053 [No Abstract] [Full Text] [Related]
45. Neonatal nonketotic hyperglycinemia: a case study and review of management for the advanced practice nurse. Mulligan JL Neonatal Netw; 2013; 32(2):95-103. PubMed ID: 23477976 [TBL] [Abstract][Full Text] [Related]
46. Non-ketotic hyperglycinemia: a life-threatening disorder in the neonate. Tada K; Kure S; Takayanagi M; Kume A; Narisawa K Early Hum Dev; 1992; 29(1-3):75-81. PubMed ID: 1396281 [TBL] [Abstract][Full Text] [Related]
47. Paradoxical increase in seizure frequency with valproate in nonketotic hyperglycinemia. Tsuyusaki Y; Shimbo H; Wada T; Iai M; Tsuji M; Yamashita S; Aida N; Kure S; Osaka H Brain Dev; 2012 Jan; 34(1):72-5. PubMed ID: 21316884 [TBL] [Abstract][Full Text] [Related]
48. AAV-mediated expression of mouse or human GLDC normalises metabolic biomarkers in a GLDC-deficient mouse model of Non-Ketotic Hyperglycinemia. Leung KY; Santos C; De Castro SCP; Diaz DG; Copp AJ; Waddington S; Greene NDE Mol Genet Metab; 2024 Jul; 142(3):108496. PubMed ID: 38761651 [TBL] [Abstract][Full Text] [Related]
49. Nonketotic hyperglycinemia: analyses of glycine cleavage system in typical and atypical cases. Hayasaka K; Tada K; Fueki N; Nakamura Y; Nyhan WL; Schmidt K; Packman S; Seashore MR; Haan E; Danks DM J Pediatr; 1987 Jun; 110(6):873-7. PubMed ID: 3585602 [TBL] [Abstract][Full Text] [Related]
50. Treatment from birth of nonketotic hyperglycinemia due to a novel GLDC mutation. Korman SH; Wexler ID; Gutman A; Rolland MO; Kanno J; Kure S Ann Neurol; 2006 Feb; 59(2):411-5. PubMed ID: 16404748 [TBL] [Abstract][Full Text] [Related]